Key Takeaway: Vir Biotechnology, Inc. announced its participation in several investor healthcare conferences in September 2023. The company will host a live webcast of a fireside chat, which will be available on their website for 30 days. Vir focuses on innovative treatments for infectious diseases and has an extensive clinical pipeline.
Price reaction · baseline $13.04 (2023-08-29 close) · hit after-hours · clean, no other VIR news in the window
day 0 close · peak
-1.1%
Market Sentiment Analysis
POSITIVE FACTORS
Vir Biotechnology is actively engaging with investors.
The company has a diverse clinical development pipeline.
Management participation in conferences indicates transparency.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
14%
average across 4 past catalysts
Lead asset
Tobevibart
Phase 3 · Viral Hepatitis
Full Press Release Details
SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that management will be participating in the following upcoming investor conferences during the month of September:
A live webcast of the fireside chat can be accessed under Events & Presentations in the Investors section of the Vir website atwww.vir.bioand will be archived there for 30 days.
About Vir BiotechnologyVir Biotechnology, Inc. is an immunology company focused on combining cutting-edge technologies to treat and prevent infectious diseases and other serious conditions. Vir has assembled two technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current clinical development pipeline consists of product candidates targeting hepatitis B and hepatitis delta viruses, influenza A and B, human immunodeficiency virus and COVID-19. Vir has several preclinical candidates in its pipeline, including RSV/MPV and HPV. Vir routinely posts information that may be important to investors on its website.
Frequently Asked Questions
What investor conferences will Vir Biotechnology attend?
Vir Biotechnology will participate in several investor healthcare conferences in September 2023.
How can I access the webcast of the fireside chat?
The webcast will be available under Events & Presentations on the Vir website.
What is the focus of Vir Biotechnology?
Vir Biotechnology focuses on treating and preventing infectious diseases using advanced technologies.
How long will the webcast be archived?
The webcast will be archived on the Vir website for 30 days.